BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 36683147)

  • 21. Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis.
    Velliquette RA; O'Connor T; Vassar R
    J Neurosci; 2005 Nov; 25(47):10874-83. PubMed ID: 16306400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease.
    Dutescu RM; Li QX; Crowston J; Masters CL; Baird PN; Culvenor JG
    Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1213-21. PubMed ID: 19271231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term oral melatonin alleviates memory deficits, reduces amyloid-β deposition associated with downregulation of BACE1 and mitophagy in APP/PS1 transgenic mice.
    Sun C; Qiu X; Wang Y; Liu J; Li Q; Jiang H; Li S; Song C
    Neurosci Lett; 2020 Sep; 735():135192. PubMed ID: 32619650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of NLRP1 inflammasome improves autophagy dysfunction and Aβ disposition in APP/PS1 mice.
    Li X; Zhang H; Yang L; Dong X; Han Y; Su Y; Li W; Li W
    Behav Brain Funct; 2023 Apr; 19(1):7. PubMed ID: 37055801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The long-term effects of intermittent theta burst stimulation on Alzheimer's disease-type pathologies in APP/PS1 mice.
    Huang H; Zhu Y; Liao L; Gao S; Tao Y; Fang X; Lian Y; Gao C
    Brain Res Bull; 2023 Oct; 202():110735. PubMed ID: 37586425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
    Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
    J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
    Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
    J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of BACE1 haploinsufficiency on APP processing and Aβ concentrations in male and female 5XFAD Alzheimer mice at different disease stages.
    Devi L; Ohno M
    Neuroscience; 2015 Oct; 307():128-37. PubMed ID: 26314636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral treatment with enoxaparin exacerbates amyloid plaque pathology in Tg2576 mice.
    Cui H; King AE; Jacobson GA; Small DH
    J Neurosci Res; 2017 Apr; 95(4):992-999. PubMed ID: 27546887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease.
    Paris D; Ganey NJ; Laporte V; Patel NS; Beaulieu-Abdelahad D; Bachmeier C; March A; Ait-Ghezala G; Mullan MJ
    J Neuroinflammation; 2010 Mar; 7():17. PubMed ID: 20211007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology.
    Cai Y; Zhang XM; Macklin LN; Cai H; Luo XG; Oddo S; Laferla FM; Struble RG; Rose GM; Patrylo PR; Yan XX
    Neurotox Res; 2012 Feb; 21(2):160-74. PubMed ID: 21725719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isoorientin Affects Markers of Alzheimer's Disease via Effects on the Oral and Gut Microbiota in APP/PS1 Mice.
    Zhang Z; Tan X; Sun X; Wei J; Li QX; Wu Z
    J Nutr; 2022 Jan; 152(1):140-152. PubMed ID: 34636875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mrp14 deficiency ameliorates amyloid β burden by increasing microglial phagocytosis and modulation of amyloid precursor protein processing.
    Kummer MP; Vogl T; Axt D; Griep A; Vieira-Saecker A; Jessen F; Gelpi E; Roth J; Heneka MT
    J Neurosci; 2012 Dec; 32(49):17824-9. PubMed ID: 23223301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual role of cofilin in APP trafficking and amyloid-β clearance.
    Liu T; Woo JA; Yan Y; LePochat P; Bukhari MZ; Kang DE
    FASEB J; 2019 Dec; 33(12):14234-14247. PubMed ID: 31646885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.
    Mao P; Manczak M; Calkins MJ; Truong Q; Reddy TP; Reddy AP; Shirendeb U; Lo HH; Rabinovitch PS; Reddy PH
    Hum Mol Genet; 2012 Jul; 21(13):2973-90. PubMed ID: 22492996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treadmill exercise decreases β-amyloid burden in APP/PS1 transgenic mice involving regulation of the unfolded protein response.
    Xia J; Li B; Yin L; Zhao N; Yan Q; Xu B
    Neurosci Lett; 2019 Jun; 703():125-131. PubMed ID: 30905823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice.
    Dewachter I; Reversé D; Caluwaerts N; Ris L; Kuipéri C; Van den Haute C; Spittaels K; Umans L; Serneels L; Thiry E; Moechars D; Mercken M; Godaux E; Van Leuven F
    J Neurosci; 2002 May; 22(9):3445-53. PubMed ID: 11978821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered amyloid-beta metabolism and deposition in genomic-based beta-secretase transgenic mice.
    Chiocco MJ; Kulnane LS; Younkin L; Younkin S; Evin G; Lamb BT
    J Biol Chem; 2004 Dec; 279(50):52535-42. PubMed ID: 15452128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.